Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02294487
What this trial is testing

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaMyeloma, MultipleMyeloma-Multiple
Wake Forest University Health Sciences 19
Not applicableStudy completedNCT02640677
What this trial is testing

Safety of 4CMenB Exposure During Pregnancy

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 2
Testing effectiveness (Phase 2)Study completedNCT00135486
What this trial is testing

Study to Evaluate GlaxoSmithKline (GSK) Biologicals' MenC-TT Vaccine and Hib-MenC-TT Vaccine in Infants

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 500
Testing effectiveness (Phase 2)Study completedNCT03433482
What this trial is testing

Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,707
Testing effectiveness (Phase 2)Study completedNCT00601731
What this trial is testing

Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months

Who this might be right for
Meningococcal Disease
Novartis Vaccines 382
Large-scale testing (Phase 3)Study completedNCT03630705
What this trial is testing

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico

Who this might be right for
Healthy Volunteers (Meningococcal Infection)
Sanofi Pasteur, a Sanofi Company 525
Testing effectiveness (Phase 2)Study completedNCT00390143
What this trial is testing

Study in Adolescents/Adults to Evaluate the Persistence up to 3.5 Yrs of GSK Biologicals Meningococcal Vaccine 134612

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 46
Large-scale testing (Phase 3)Study completedNCT01453348
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine

Who this might be right for
Meningococcal DiseaseMeningococcal MeningitisHepatitis A+1 more
Novartis Vaccines 252
Post-approval studies (Phase 4)Study completedNCT03125616
What this trial is testing

Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B

Who this might be right for
PrematurityVaccinationMeningococcal Disease
St George's, University of London 136
Not applicableEnded earlyNCT03549325
What this trial is testing

A Study Assessing Colonisation & Immunogenicity After Nasal Inoculation With N. Lactamica and Eradication on Day 4 or 14

Who this might be right for
Meningitis, Meningococcal
University Hospital Southampton NHS Foundation Trust 21
Large-scale testing (Phase 3)Study completedNCT01345721
What this trial is testing

Persistence Of Antibody Responses Among Children Who Previously Received Novartis MenACWY Conjugate Vaccine or Meningococcal C Conjugate Vaccine

Who this might be right for
Meningococcal Disease
Novartis Vaccines 205
Large-scale testing (Phase 3)Study completedNCT00450437
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults

Who this might be right for
Meningococcal InfectionsMeningococcal Meningitis
Novartis Vaccines 3,539
Post-approval studies (Phase 4)Study completedNCT00392808
What this trial is testing

Immunogenicity of the Booster Dose of Two MenC Vaccines

Who this might be right for
Meningococcal Infection
Centro Superior de Investigación en Salud Publica 389
Testing effectiveness (Phase 2)Study completedNCT03295318
What this trial is testing

Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds

Who this might be right for
Meningitis, Meningococcal
Serum Institute of India Pvt. Ltd. 375
Early research (Phase 1)Study completedNCT04236960
What this trial is testing

Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.

Who this might be right for
Meningococcal Infections
Walvax Biotechnology Co., Ltd. 100
Post-approval studies (Phase 4)Study completedNCT00454987
What this trial is testing

Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria MeningitidisNeisseria Meningitidis-Haemophilus Influenzae Type b Vaccine
GlaxoSmithKline 288
Large-scale testing (Phase 3)UnknownNCT02858570
What this trial is testing

Conjugate Vaccine Against Meningococcus C a Brazilian Project

Who this might be right for
Serogroup C Meningococcal Meningitis
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,644
Large-scale testing (Phase 3)UnknownNCT04689165
What this trial is testing

A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine

Who this might be right for
Meningitis, Meningococcal
Wei Cun 1,280
Testing effectiveness (Phase 2)Study completedNCT00459316
What this trial is testing

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth

Who this might be right for
HIV InfectionsMeningitis
National Institute of Allergy and Infectious Diseases (NIAID) 384
Testing effectiveness (Phase 2)Active Not RecruitingNCT06647407
What this trial is testing

Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

Who this might be right for
Meningococcal ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 750
Next Page